Pharmacist-led antifungal reviews in cancer care
Author Information
Author(s): Akbar Zunaira, Aamir Muhammad, Saleem Zikria, Khan Muhammad Rehan, Bhutta Omar Akhlaq
Primary Institution: Shaukat Khanum Memorial Cancer Hospital and Research Centre
Hypothesis
The study aimed to evaluate the effectiveness of clinical pharmacist-led antifungal drug utilization reviews in optimizing antifungal therapy in cancer patients.
Conclusion
Pharmacists significantly improve antifungal therapy management through targeted interventions in cancer patients.
Supporting Evidence
- Pharmacists conducted drug utilization reviews for 350 cancer patients.
- 100% of pharmacist interventions were accepted by the AFS team.
- Most patients were prescribed antifungals for suspected fungal infections.
Takeaway
Pharmacists help make sure cancer patients get the right antifungal medicines, which can make them feel better and avoid side effects.
Methodology
A prospective audit and feedback study was conducted, reviewing electronic medical records of 350 cancer patients prescribed systemic antifungals.
Limitations
The study focused only on cancer patients with systemic fungal infections and could not ascertain the effects of pharmacist interventions on mortality or length of hospital stay.
Participant Demographics
{"gender":{"male":218,"female":132},"age_group":{"adult":177,"paediatric":173},"weight":{"over_45kg":155,"under_15kg":93,"16_to_30kg":55,"31_to_45kg":47},"type_of_cancer":{"leukaemia":168,"lymphoma":80,"carcinoma":33,"sarcoma":26,"others":43},"febrile_neutropenia":194}
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website